LON:VRP - Verona Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 60 0.00 (0.00 %)
(As of 04/24/2019 04:10 AM ET)
Previous CloseGBX 60
Today's RangeGBX 59 - GBX 60.89
52-Week RangeGBX 48 - GBX 168
Volume10,129 shs
Average Volume49,797 shs
Market Capitalization£63.23 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.

Receive VRP News and Ratings via Email

Sign-up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-32834200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 61.40 per share
Book ValueGBX 59.80 per share

Profitability

Miscellaneous

Employees22
Market Cap£63.23 million
Next Earnings DateN/A
OptionableOptionable

Verona Pharma (LON:VRP) Frequently Asked Questions

What is Verona Pharma's stock symbol?

Verona Pharma trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How were Verona Pharma's earnings last quarter?

Verona Pharma Plc (LON:VRP) released its earnings results on Tuesday, May, 8th. The company reported ($14.50) EPS for the quarter, beating the consensus estimate of ($23.70) by $9.20. View Verona Pharma's Earnings History.

What price target have analysts set for VRP?

2 brokerages have issued 1 year price objectives for Verona Pharma's shares. Their predictions range from GBX 160 to GBX 160. On average, they expect Verona Pharma's share price to reach GBX 160 in the next twelve months. This suggests a possible upside of 166.7% from the stock's current price. View Analyst Price Targets for Verona Pharma.

What is the consensus analysts' recommendation for Verona Pharma?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verona Pharma in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Verona Pharma.

Has Verona Pharma been receiving favorable news coverage?

News stories about VRP stock have trended somewhat positive recently, InfoTrie reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Verona Pharma earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.

Who are some of Verona Pharma's key competitors?

What other stocks do shareholders of Verona Pharma own?

Who are Verona Pharma's key executives?

Verona Pharma's management team includes the folowing people:
  • Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)
  • Mr. Piers John Morgan, Chief Financial Officer (Age 53)
  • Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)
  • Ms. Victoria Stewart, Director of Communications
  • Dr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57)

How do I buy shares of Verona Pharma?

Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Verona Pharma's stock price today?

One share of VRP stock can currently be purchased for approximately GBX 60.

How big of a company is Verona Pharma?

Verona Pharma has a market capitalization of £63.23 million. Verona Pharma employs 22 workers across the globe.

What is Verona Pharma's official website?

The official website for Verona Pharma is http://www.veronapharma.com/.

How can I contact Verona Pharma?

Verona Pharma's mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200.


MarketBeat Community Rating for Verona Pharma (LON VRP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  183 (Vote Outperform)
Underperform Votes:  189 (Vote Underperform)
Total Votes:  372
MarketBeat's community ratings are surveys of what our community members think about Verona Pharma and other stocks. Vote "Outperform" if you believe VRP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel